Unknown

Dataset Information

0

22q11.2q13 duplication including SOX10 causes sex-reversal and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease.

ABSTRACT: Diagnosis of genetic syndromes may be difficult when specific components of a disorder manifest at a later age. We present a follow up of a previous report [Seeherunvong et al., (2004); AJMGA 127: 149-151], of an individual with 22q duplication and sex-reversal syndrome. The subject's phenotype evolved to include peripheral and central demyelination, Waardenburg syndrome type IV, and Hirschsprung disease (PCWH; MIM 609136). DNA microarray analysis defined the duplication at 22q11.2q13, including SOX10. Sequencing of the coding region of SOX10 did not reveal any mutations. Our data suggest that SOX10 duplication can cause disorders of sex development and PCWH, supporting the hypothesis that SOX10 toxic gain of function rather than dominant negative activity underlies PCWH.

SUBMITTER: Falah N 

PROVIDER: S-EPMC5536953 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

22q11.2q13 duplication including SOX10 causes sex-reversal and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease.

Falah Nadia N   Posey Jennifer E JE   Thorson Willa W   Benke Paul P   Tekin Mustafa M   Tarshish Brocha B   Lupski James R JR   Harel Tamar T  

American journal of medical genetics. Part A 20170401 4

Diagnosis of genetic syndromes may be difficult when specific components of a disorder manifest at a later age. We present a follow up of a previous report [Seeherunvong et al., (2004); AJMGA 127: 149-151], of an individual with 22q duplication and sex-reversal syndrome. The subject's phenotype evolved to include peripheral and central demyelination, Waardenburg syndrome type IV, and Hirschsprung disease (PCWH; MIM 609136). DNA microarray analysis defined the duplication at 22q11.2q13, including  ...[more]

Similar Datasets

Unknown A novel frameshift mutation in SOX10 causes Waardenburg syndrome with peripheral demyelinating neuropathy, visual impairment and the absence of Hirschsprung disease.
| S-EPMC7167353 | biostudies-literature
Unknown Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease.
| S-EPMC10233759 | biostudies-literature
Unknown Aberrant SOX10 and RET expressions in patients with Hirschsprung disease.
| S-EPMC10943800 | biostudies-literature
Unknown Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4.
| S-EPMC3421117 | biostudies-literature
Unknown Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2.
| S-EPMC3407046 | biostudies-literature
Unknown A novel frameshift mutation in SOX10 gene induced Waardenburg syndrome type II.
| S-EPMC10958176 | biostudies-literature
Unknown Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.
| S-EPMC4098937 | biostudies-literature
Unknown Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.
| S-EPMC2276340 | biostudies-literature
Unknown Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations.
| S-EPMC7964579 | biostudies-literature
Unknown Exclusion of RET and Pax 3 loci in Waardenburg-Hirschsprung disease.
| S-EPMC1050384 | biostudies-other